X-Nico

unusual facts about growth factor


Neurotrophic electrode

The glass cone is only 1–2 mm long, and is filled with trophic factors in order to encourage axons and dendrites to grow through its tip and hollow body.


Keratinocyte growth factor

The Keratinocyte Growth Factor (KGF), also known as FGF7, is a growth factor present in the epithelialization-phase of wound healing.


see also

Adrenocortical carcinoma

The genes h19, insulin-like growth factor II (IGF-II), p57kip2 are important for fetal growth and development.

CFC domain

In molecular biology, the CFC domain (Cripto Frl-1 Cryptic domain) is a protein domain found at the C-terminus of a number of proteins including Cripto (or teratocarcinoma-derived growth factor).

Fibroblast growth factor receptor 4

Fibroblast growth factor receptor 4 has been shown to interact with FGF1.

HTRA1

They are from amino-terminus to carboxyl-terminus an Insulin-like growth factor binding domain, a kazal domain, a trypsin-like peptidase domain and a PDZ domain.

Huntingtin-associated protein 1

This gene encodes a protein that interacts with huntingtin, with two cytoskeletal proteins (dynactin and pericentriolar autoantigen protein 1), and with a hepatocyte growth factor-regulated tyrosine kinase substrate (HGS).

IGFBP7 RNA editing

Insulin like growth factor binding protein 7 (IGFBP7) is a 282 amino acid long protein encoded by the IGFBP7 gene.

Insulin-like growth factor 2 receptor

Insulin-like growth factor 2 receptor has been shown to interact with M6PRBP1.

Insulin-like growth factor II IRES

The insulin-like growth factor II (IGF-II) internal ribosome entry site IRES is found in the 5' UTR of IGF-II leader 2 mRNA.

Interleukin 2

It was initially called T cell growth factor, but the name was changed in 1978 to IL-2 (interleukin-2) by the Interlaken cytokine nomenclature committee.

KITR

KIT receptor, a membrane-bound receptor for mast/stem cell growth factor.

Paola S. Timiras

At UC Berkeley, Timiras studied the effects of caloric restriction on various hypothalamic nuclei, specifically the effects on cell density, estrogen receptor alpha immunoreactivity and insulin-like growth factor-1 (IGF-1) receptor immunoreactivity.

Quizartinib

Specifically, Quizartinib selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3 (FLT3/STK1), colony-stimulating factor 1 receptor (CSF1R/FMS), stem cell factor receptor (SCFR/KIT), and platelet derived growth factor receptors (PDGFRs).

Transforming growth factor, beta 3

Transforming growth factor, beta 3 has been shown to interact with TGF beta receptor 2.